Glioblastoma is a formidable cancer that medicine cannot cure.
At least, not yet.
This very aggressive brain tumor affects around 3,000 people each year in France.
“
It is one of the cancers with the worst prognosis and one of those for which treatments have progressed the least over the last ten years ,
”
notes Professor Olivier Chinot, head of the neuro-oncology department at the Timone hospital (Marseille).
Despite numerous obstacles, this cancer continues to be the subject of very active research, suggesting the arrival of new therapies in the coming years.
A team from Massachusetts General Hospital in Boston has just revealed the results of a new treatment in the prestigious
New England Journal of Medicine
.
And these are very promising, even if they are still preliminary.
While many types of cancer have benefited from the development of immunotherapies – a therapeutic strategy…
This article is reserved for subscribers.
You have 78% left to discover.
Flash sale
€4.49/month for 12 months
I ENJOY IT
Already subscribed?
Log in